Clinical trial
Prospective Randomized Multi-center Controlled Clinical Investigation Comparing Patent Foramen Ovale (PFO) Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion
NCT05069558 is registered in ClinicalTrials.gov with Occlutech International AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomized Multi-center Controlled Clinical Investigation Comparing Patent Foramen Ovale (PFO) Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion
- Lead sponsor
- Occlutech International AB
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 9, 2022
- Completion date
- November 30, 2029
- Enrollment
- 450 (estimated)
- Sites
- 48
Conditions
As the registry lists them; a condition with its own page is linked.
patent foramen ovale, pfo, stroke